Before you sell to, join or invest in Biolinq Inc
MentionFox check on Biolinq Inc: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/biolinq-inc-form-d-25000001
Check Biolinq Inc before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Biolinq Inc?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Biolinq Inc filed a Form D with the Securities and Exchange Commission on 2025-03-21.
Biolinq Inc filed a Form D notice of an exempt securities offering with the SEC on March 21, 2025. The filing reports $90M sold. Its industry group is Biotechnology. It names RICHARD YANG (Executive Officer, Director), CHRIS DIMITROPOULOS (Director), DEREK RAPP (Director) (SEC Form D, March 21, 2025).
Is this your company?
Sell to companies like Biolinq Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-03-21 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Biolinq Inc.
Free to see. No signup.
More on the people and the money behind Biolinq Inc, from the filings we hold.
Biotechnology raises by companies based in California, filed in March 2025, largest first.
Get an email when Biolinq Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Biolinq Inc raises, hires or launches. No email unless you switch it on.
Watch Biolinq Inc →Get the full cited report on Biolinq Inc
What the filing shows about Biolinq Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Biolinq Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Biolinq Inc's address as 10260 Sorrento Valley Road, San Diego, CA 92121.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Biolinq Inc is a registered filer with the SEC (CIK 1685406) and has filed since 2023-12-26. 4 filings are on record, the latest on 2025-03-21.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Biolinq Inc's Form D of 2025-03-21 names RICHARD YANG, CHRIS DIMITROPOULOS, DEREK RAPP and 6 more as its officers, directors or promoters.
Its new offerings report $125.11M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Richard Yang is named as Executive Officer and Director on the Form D that Biolinq Inc filed with the SEC on 21 March 2025, one of 9 people that filing names.
Chris Dimitropoulos is named as Director on the Form D that Biolinq Inc filed with the SEC on 21 March 2025, one of 9 people that filing names.
Derek Rapp is named as Director on the Form D that Biolinq Inc filed with the SEC on 21 March 2025, one of 9 people that filing names.
Thad Johnson is named as Director on the Form D that Biolinq Inc filed with the SEC on 21 March 2025, one of 9 people that filing names.
Dan Bradbury is named as Director on the Form D that Biolinq Inc filed with the SEC on 21 March 2025, one of 9 people that filing names.
Zina Besse is named as Director on the Form D that Biolinq Inc filed with the SEC on 21 March 2025, one of 9 people that filing names.
David Berry is named as Director on the Form D that Biolinq Inc filed with the SEC on 21 March 2025, one of 9 people that filing names.
Jared Tangney is named as Executive Officer on the Form D that Biolinq Inc filed with the SEC on 21 March 2025, one of 9 people that filing names.
David Arida is named as Executive Officer on the Form D that Biolinq Inc filed with the SEC on 21 March 2025, one of 9 people that filing names.
9 people named on the filing — 3 holding an executive role and 6 as directors only.
Named as of the 2025-03-21 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Biolinq Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Biolinq Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Biolinq Inc covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Biolinq IncYou get an alert in MentionFox the next time this company shows up.
If you're behind Biolinq Inc: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Biolinq Inc. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Diego
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/biolinq-inc-form-d-25000001